Biblio
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer. J Exp Clin Cancer Res. 2023;42(1):204.
Efficient exon skipping by base-editor-mediated abrogation of exonic splicing enhancers. Cell Rep. 2023;42(11):113340.
. .